Recall of Symjepi (epinephrine) Injection 0.15 mg (0.15 mg/0.3 mL) and 0.3 mg (0.3 mg/0.3 mL) Pre-Filled Single-Dose Syringes
On April 13, 2022, the U.S. Food and Drug Administration (FDA) announced that Adamis Pharmaceuticals is voluntarily recalling certain lots of Symjepi (epinephrine) Injection 0.15 mg (0.15 mg/0.3 mL) and 0.3 mg (0.3 mg/0.3 mL) Pre-Filled Single-Dose Syringes as a Class I Recall. This is due to concerns that clogs in needles can prevent dispensing of epinephrine.
Please note that not all lots are affected, so you may not be affected by this recall. Your health and safety are important to us. If you are currently taking Symjepi (epinephrine) Injection, please contact your health care provider to talk about other treatments or medicines that may be appropriate.
For more information, please visit FDA.gov. You can also contact US WorldMeds at 1-888-900-8796 (TTY 711), weekdays, 8 a.m. to 4 p.m., or by email. The Horizon NJ Health Pharmacy Help Desk is available at 1-800-682-9094 x81016 (TTY 711), weekdays, 8 a.m. to 5 p.m., and Saturday, 8 a.m. to 4:30 p.m.